Literature DB >> 20927123

TAT-mediated delivery of a DNA repair enzyme to skin cells rapidly initiates repair of UV-induced DNA damage.

Jodi L Johnson1, Brian C Lowell, Olga P Ryabinina, R Stephen Lloyd, Amanda K McCullough.   

Abstract

UV light causes DNA damage in skin cells, leading to more than one million cases of non-melanoma skin cancer diagnosed annually in the United States. Although human cells possess a mechanism (nucleotide excision repair) to repair UV-induced DNA damage, mutagenesis still occurs when DNA is replicated before repair of these photoproducts. Although human cells have all the enzymes necessary to complete an alternate repair pathway, base excision repair (BER), they lack a DNA glycosylase that can initiate BER of dipyrimidine photoproducts. Certain prokaryotes and viruses produce pyrimidine dimer-specific DNA glycosylases (pdgs) that initiate BER of cyclobutane pyrimidine dimers (CPDs), the predominant UV-induced lesions. Such a pdg was identified in the Chlorella virus PBCV-1 and termed Cv-pdg. The Cv-pdg protein was engineered to contain a nuclear localization sequence (NLS) and a membrane permeabilization peptide (transcriptional transactivator, TAT). Here, we demonstrate that the Cv-pdg-NLS-TAT protein was delivered to repair-proficient keratinocytes and fibroblasts, and to a human skin model, where it rapidly initiated removal of CPDs. These data suggest a potential strategy for prevention of human skin cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20927123      PMCID: PMC3203208          DOI: 10.1038/jid.2010.300

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  39 in total

1.  Mechanisms and implications of the age-associated decrease in DNA repair capacity.

Authors:  D Goukassian; F Gad; M Yaar; M S Eller; U S Nehal; B A Gilchrest
Journal:  FASEB J       Date:  2000-07       Impact factor: 5.191

Review 2.  The 500 Dalton rule for the skin penetration of chemical compounds and drugs.

Authors:  J D Bos; M M Meinardi
Journal:  Exp Dermatol       Date:  2000-06       Impact factor: 3.960

Review 3.  Protein transduction domains: are they delivering?

Authors:  Isabelle Green; Richard Christison; Catherine J Voyce; Ken R Bundell; Mark A Lindsay
Journal:  Trends Pharmacol Sci       Date:  2003-05       Impact factor: 14.819

4.  Chlorella virus pyrimidine dimer glycosylase excises ultraviolet radiation- and hydroxyl radical-induced products 4,6-diamino-5-formamidopyrimidine and 2,6-diamino-4-hydroxy-5-formamidopyrimidine from DNA.

Authors:  Pawel Jaruga; Ritche Jabil; Amanda K McCullough; Henry Rodriguez; Miral Dizdaroglu; R Stephen Lloyd
Journal:  Photochem Photobiol       Date:  2002-02       Impact factor: 3.421

5.  Reconstructed skin equivalents for assessing percutaneous drug absorption from pharmaceutical formulations.

Authors:  N Zghoul; R Fuchs; C M Lehr; U F Schaefer
Journal:  ALTEX       Date:  2001       Impact factor: 6.043

6.  Identification of a non-dividing subpopulation of mouse and human epidermal cells exhibiting high levels of persistent ultraviolet photodamage.

Authors:  D L Mitchell; B Volkmer; E W Breitbart; M Byrom; M G Lowery; R Greinert
Journal:  J Invest Dermatol       Date:  2001-09       Impact factor: 8.551

7.  Differential requirement for the stress-activated protein kinase/c-Jun NH(2)-terminal kinase in RNAdamage-induced apoptosis in primary and in immortalized fibroblasts.

Authors:  M S Iordanov; J Wong; D L Newton; S M Rybak; R K Bright; R A Flavell; R J Davis; B E Magun
Journal:  Mol Cell Biol Res Commun       Date:  2000-08

8.  Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group.

Authors:  D Yarosh; J Klein; A O'Connor; J Hawk; E Rafal; P Wolf
Journal:  Lancet       Date:  2001-03-24       Impact factor: 79.321

Review 9.  Tumors in organ transplant recipients may give clues to their control by immunity.

Authors:  S Abgrall; D Orbach; L Bonhomme-Faivre; S Orbach-Arbouys
Journal:  Anticancer Res       Date:  2002 Nov-Dec       Impact factor: 2.480

10.  Enhanced repair of cyclobutane pyrimidine dimers and improved UV resistance in photolyase transgenic mice.

Authors:  Wouter Schul; Judith Jans; Yvonne M A Rijksen; Kyra H M Klemann; Andre P M Eker; Jan de Wit; Osamu Nikaido; Satoshi Nakajima; Akira Yasui; Jan H J Hoeijmakers; Gijsbertus T J van der Horst
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

View more
  5 in total

1.  A Phage Lysin Fused to a Cell-Penetrating Peptide Kills Intracellular Methicillin-Resistant Staphylococcus aureus in Keratinocytes and Has Potential as a Treatment for Skin Infections in Mice.

Authors:  ZhaoFei Wang; LiCheng Kong; Yang Liu; Qiang Fu; ZeLin Cui; Jian Wang; JingJiao Ma; HengAn Wang; YaXian Yan; JianHe Sun
Journal:  Appl Environ Microbiol       Date:  2018-05-31       Impact factor: 4.792

2.  Modulation of the processive abasic site lyase activity of a pyrimidine dimer glycosylase.

Authors:  Olga P Ryabinina; Irina G Minko; Michael R Lasarev; Amanda K McCullough; R Stephen Lloyd
Journal:  DNA Repair (Amst)       Date:  2011-09-01

Review 3.  Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials.

Authors:  Joanne M Jeter; Tawnya L Bowles; Clara Curiel-Lewandrowski; Susan M Swetter; Fabian V Filipp; Zalfa A Abdel-Malek; Larisa J Geskin; Jerry D Brewer; Jack L Arbiser; Jeffrey E Gershenwald; Emily Y Chu; John M Kirkwood; Neil F Box; Pauline Funchain; David E Fisher; Kari L Kendra; Ashfaq A Marghoob; Suephy C Chen; Michael E Ming; Mark R Albertini; John T Vetto; Kim A Margolin; Sherry L Pagoto; Jennifer L Hay; Douglas Grossman; Darrel L Ellis; Mohammed Kashani-Sabet; Aaron R Mangold; Svetomir N Markovic; Frank L Meyskens; Kelly C Nelson; Jennifer G Powers; June K Robinson; Debjani Sahni; Aleksandar Sekulic; Vernon K Sondak; Maria L Wei; Jonathan S Zager; Robert P Dellavalle; John A Thompson; Martin A Weinstock; Sancy A Leachman; Pamela B Cassidy
Journal:  Cancer       Date:  2018-10-03       Impact factor: 6.860

4.  Prospects for skin cancer treatment and prevention: the potential contribution of an engineered virus.

Authors:  Jennifer A Cafardi; Rubina Shafi; Mohammad Athar; Craig A Elmets
Journal:  J Invest Dermatol       Date:  2011-03       Impact factor: 8.551

5.  Inhibition of DNA glycosylases via small molecule purine analogs.

Authors:  Aaron C Jacobs; Marcus J Calkins; Ajit Jadhav; Dorjbal Dorjsuren; David Maloney; Anton Simeonov; Pawel Jaruga; Miral Dizdaroglu; Amanda K McCullough; R Stephen Lloyd
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.